(Q41791586)

10 October 2017

Cisplatin induced emesis: preliminary results indicative of changes in plasma levels of 5-hydroxytryptamine (English)

1 reference

ORCID Public Data File 2021

10 October 2017

1 reference

author name string

Barnes NM

1

1 reference

10 October 2017

Ge J

2

1 reference

10 October 2017

Jones WG

3

1 reference

10 October 2017

Naylor RJ

4

1 reference

10 October 2017

Rudd JA

5

1 reference

10 October 2017

language of work or name

English

0 references

publication date

1 November 1990

1 reference

British Journal of Cancer

10 October 2017

1 reference

10 October 2017

62

1 reference

10 October 2017

5

1 reference

10 October 2017

862-864

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1990.395

10 October 2017

0 references

cites work

Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971539

Neuropharmacology of emesis induced by anti-cancer therapy.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971539

5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971539

Serotonergic status in human blood

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971539

Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and Vomiting

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971539

Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971539

Serum prostaglandin F-2 alpha concentration in the carcinoid syndrome

16 June 2018

1 reference

12 December 2020

Measurement of free and bound 5-hydroxytryptophan in plasma by liquid chromatography with electrochemical detection

1 reference

12 December 2020

5-Hydroxytryptamine M-receptor antagonism to prevent cisplatin-induced emesis

1 reference

12 December 2020

First results with ICS 205-930 (5-HT3 receptor antagonist) in prevention of chemotherapy-induced emesis

1 reference

12 December 2020

PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONIST

1 reference

12 December 2020

Phase II trials of the serotonin antagonist GR38032F for the control of vomiting caused by cisplatin

1 reference

12 December 2020

The role of the abdominal visceral innervation and 5-hydroxytryptamine M-receptors in vomiting induced by the cytotoxic drugs cyclophosphamide and cis-platin in the ferret

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1990.395

1 reference

10 October 2017

1 reference

10 October 2017

PubMed publication ID

2173945

1 reference